DOXORUBICIN for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 41 adverse event reports in the FDA FAERS database where DOXORUBICIN was used for Off label use.
Most Reported Side Effects for DOXORUBICIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 8,844 | 10.7% | 1,075 | 5,491 |
| Off label use | 7,858 | 9.5% | 1,712 | 2,385 |
| Disease progression | 6,165 | 7.5% | 1,384 | 865 |
| Neutropenia | 5,891 | 7.1% | 927 | 2,104 |
| Drug ineffective | 4,598 | 5.6% | 1,342 | 1,068 |
| Pyrexia | 3,697 | 4.5% | 482 | 2,503 |
| Thrombocytopenia | 3,638 | 4.4% | 645 | 1,330 |
| Anaemia | 3,601 | 4.4% | 555 | 1,566 |
| Product use in unapproved indication | 3,502 | 4.2% | 821 | 978 |
| Nausea | 2,925 | 3.5% | 279 | 1,405 |
| Sepsis | 2,740 | 3.3% | 1,481 | 1,198 |
| Pneumonia | 2,611 | 3.2% | 839 | 1,521 |
| Death | 2,515 | 3.0% | 2,514 | 299 |
| Diarrhoea | 2,330 | 2.8% | 403 | 1,216 |
| Vomiting | 2,279 | 2.8% | 310 | 1,233 |
Other Indications for DOXORUBICIN
Diffuse large b-cell lymphoma (15,213)
Product used for unknown indication (5,186)
Hodgkin's disease (4,606)
B-cell lymphoma (3,947)
Breast cancer (3,641)
Non-hodgkin's lymphoma (3,298)
Acute lymphocytic leukaemia (3,128)
Plasma cell myeloma (2,820)
Chemotherapy (1,756)
Ovarian cancer (1,692)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)